Yvette Roke
Overview
Explore the profile of Yvette Roke including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
97
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van Asselt A, Hoeberichts K, Demirel S, Scheeren A, Roke Y
Front Psychiatry
. 2025 Jan;
15():1469257.
PMID: 39845363
Objective: Studies indicate that stress levels of autistic adolescents may be particularly high. Therefore, support is needed to help them deal with their stressors. Stress Autism Mate (SAM) Junior, a...
2.
Bernaerts S, Van Daele T, Carlsen C, Nielsen S, Schaap J, Roke Y
Front Digit Health
. 2024 Sep;
6:1440660.
PMID: 39238496
No abstract available.
3.
Hoeberichts K, Roke Y, Niks I, van Harten P
Front Psychiatry
. 2024 Jun;
15:1347947.
PMID: 38938455
Introduction: The mobile health application "Stress Autism Mate" (SAM) was designed to support adults with autism in identifying and managing daily stress. SAM measures stress four times daily, provides a...
4.
Dinnissen M, Dietrich A, Bierens M, van der Molen J, Verhallen A, Overbeek W, et al.
J Child Adolesc Psychopharmacol
. 2024 Apr;
34(6):253-263.
PMID: 38669110
Risperidone is commonly prescribed off-label in children and adolescents to manage disruptive behavior. This study aimed to investigate continued benefits of risperidone after at least 1 year of treatment and...
5.
Demirel S, Roke Y, Hoogendoorn A, Hoefakker J, Hoeberichts K, van Harten P
J Med Internet Res
. 2024 Jan;
26:e48883.
PMID: 38275128
Background: Work-related stress and burnout remain common problems among employees, leading to impaired health and higher absenteeism. The use of mobile health apps to promote well-being has grown substantially; however,...
6.
Roke Y, van Harten P, Franke B, Galesloot T, Boot A, Buitelaar J
Pharmacogenet Genomics
. 2013 Jul;
23(9):487-93.
PMID: 23851570
Objective: To investigate the effect of the Taq1A variant in the Dopamine D2 receptor gene (DRD2) and common functional genetic variants in the cytochrome P450 2D6 gene (CYP2D6) on prolactin...
7.
Roke Y, Buitelaar J, Boot A, Tenback D, van Harten P
J Child Adolesc Psychopharmacol
. 2012 Dec;
22(6):432-9.
PMID: 23234586
Objective: The aim of this study was to investigate the long-term treatment effects of risperidone on prolactin levels and prolactin-related side effects in pubertal boys with autism spectrum disorders (ASD)...
8.
Roke Y, van Harten P, Buitelaar J, Tenback D, Quekel L, de Rijke Y, et al.
Eur J Endocrinol
. 2012 Sep;
167(6):855-63.
PMID: 23011870
Objective: To investigate the long-term effects of antipsychotic (AP) treatment and AP-induced hyperprolactinemia on bone mineral density (BMD) and body composition in male adolescents with autism spectrum disorders (ASDs) and/or...
9.
Roke Y, van Harten P, Buitelaar J, Tenback D, de Rijke Y, Boot A
Horm Res Paediatr
. 2012 Apr;
77(4):235-40.
PMID: 22538969
Aims: This cross-sectional study investigates the effect of antipsychotic (AP)-induced hyperprolactinemia on testosterone, luteinizing hormone (LH), follicle-stimulating hormone (FSH), inhibin B, and puberty in boys with mainly autism spectrum disorders...
10.
Roke Y, van Harten P, Boot A, Buitelaar J
J Child Adolesc Psychopharmacol
. 2009 Aug;
19(4):403-14.
PMID: 19702492
Objective: This review reports the incidence of hyperprolactinemia, its relationship with genotype, and prolactin-related side effects in children and adolescents treated with antipsychotics. Method: Data on prolactin levels were available...